Objective: To assess the clinical applicability, safety and initial efficacy of a new laparoscopic retroperitoneal hysteropexy technique.
Study design: A relatively homogeneous group of patients (N = 62) with symptomatic uterine retroflexion was randomly allocated to laparoscopic retroperitoneal uterine suspension (n = 32, group I) and diagnostic laparoscopy (n = 30, group II). Patients from both groups were followed for at least 24 months. The following clinical parameters were compared between groups I (treated) and II (untreated): deep dyspareunia, dysmenorrhea, sense of bladder pressure with frequent urination and sense of pressure in the rectum.
Results: Surgery was performed as an outpatient operation by the author. Intraoperative or postoperative complications were not observed in either group. A prospective, double-blind, controlled trial revealed that 87.5% of patients with symptomatic uterine retroflexion experienced relief from symptoms after the operation. Statistical analysis of the two groups documented that clinical symptoms improved (with P < .0001) in a statistically significant number of cases among patients subjected to hysteropexy.
Conclusion: Laparoscopic retroperitoneal uterine suspension benefitted patients and was safe.